Carolin Mügge

Dr. Carolin Mügge

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KKKatharina Köninger
Katharina Köninger
ÁBÁlvaro Gómez Baraibar
Álvaro Gómez Baraibar
CMCarolin Mügge
Carolin Mügge
CPCaroline E. Paul
Caroline E. Paul
Frank HollmannFrank Hollmann
Frank Hollmann
RKRobert Kourist
Robert Kourist

18 October 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ABAlvaro Gomez Baraibar
Alvaro Gomez Baraibar
DRDennis Reichert
Dennis Reichert
CMCarolin Mügge
Carolin Mügge
SSSvenja Seger
Svenja Seger
HGHarald Gröger
Harald Gröger
RKRobert Kourist
Robert Kourist

12 April 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
KAKarim Aljakouch
Karim Aljakouch
TLTatjana Lechtonen
Tatjana Lechtonen
HYHesham K. Yosef
Hesham K. Yosef
MHMohamad K. Hammoud
Mohamad K. Hammoud
WAWissam Alsaidi
Wissam Alsaidi
KGKlaus Gerwert
Klaus Gerwert
Tyrosine kinase receptors are one of the main targets in cancer therapy. They play an essential role in the modulation of growth factor signaling and thereby inducing cell proliferation and growth. Tyrosine kinase inhibitors such as neratinib bind to EGFR and HER2 receptors and exhibit antitumor activity. However, little is known about their detailed cellular uptake and metabolism. Here, we report for the first time the intracellular spatial distribution and metabolism of neratinib in different cancer cells using label‐free Raman imaging. Two new neratinib metabolites were detected and fluorescence imaging of the same cells indicate that neratinib accumulates in lysosomes. The results also suggest that both EGFR and HER2 follow the classical endosome lysosomal pathway for degradation. A combination of Raman microscopy, DFT calculations, and LC‐MS was used to identify the chemical structure of neratinib metabolites. These results show the potential of Raman microscopy to study drug pharmacokinetics.

5 June 2020 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
CMCarolin Mügge
Carolin Mügge
THThomas Heine
Thomas Heine
ABAlvaro Gomez Baraibar
Alvaro Gomez Baraibar
Willem Berkel vanWillem Berkel van
Willem Berkel van
CPCaroline E. Paul
Caroline E. Paul
Dirk TischlerDirk Tischler
Dirk Tischler
Amino groups derived from naturally abundant amino acids or (di)amines can be used as “shuttles” in nature for oxygen transfer to provide intermediates or products comprising N-O functional groups such as N-hydroxy, oxazine, isoxazolidine, nitro, nitrone, oxime, C-, S-, or N-nitroso, and azoxy units. To this end, molecular oxygen is activated by flavin, heme, or metal cofactor-containing enzymes and transferred to initially obtain N-hydroxy compounds, which can be further functionalized. In this review, we focus on flavin-dependent N-hydroxylating enzymes, which play a major role in the production of secondary metabolites, such as siderophores or antimicrobial agents. Flavoprotein monooxygenases of higher organisms (among others, in humans) can interact with nitrogen-bearing secondary metabolites or are relevant with respect to detoxification metabolism and are thus of importance to understand potential medical applications. Many enzymes that catalyze N-hydroxylation reactions have specific substrate scopes and others are rather relaxed. The subsequent conversion towards various N-O or N-N comprising molecules is also described. Overall, flavin-dependent N-hydroxylating enzymes can accept amines, diamines, amino acids, amino sugars, and amino aromatic compounds and thus provide access to versatile families of compounds containing the N-O motif. Natural roles as well as synthetic applications are highlighted. Key points• N-O and N-N comprising natural and (semi)synthetic products are highlighted.• Flavin-based NMOs with respect to mechanism, structure, and phylogeny are reviewed.• Applications in natural product formation and synthetic approaches are provided.

17 August 2017 in Catalysts
Verified
Journal Article
Open access
PDF file
SBStefanie Böhmer
Stefanie Böhmer
KKKatharina Köninger
Katharina Köninger
ABAlvaro Gomez Baraibar
Alvaro Gomez Baraibar
SBSamiro Bojarra
Samiro Bojarra
CMCarolin Mügge
Carolin Mügge
RKRobert Kourist
Robert Kourist
Photosynthetic water-splitting is a powerful force to drive selective redox reactions. The need of highly expensive redox partners such as NADPH and their regeneration is one of the main bottlenecks for the application of biocatalysis at an industrial scale. Recently, the possibility of using the photosystem of cyanobacteria to supply high amounts of reduced nicotinamide to a recombinant enoate reductase opened a new strategy for overcoming this hurdle. This paper presents the expansion of the photosynthetic regeneration system to a Baeyer–Villiger monooxygenase. Despite the potential of this strategy, this work also presents some of the encountered challenges as well as possible solutions, which will require further investigation. The successful enzymatic oxygenation shows that cyanobacterial whole-cell biocatalysis is an applicable approach that allows fuelling selective oxyfunctionalisation reactions at the expense of light and water. Yet, several hurdles such as side-reactions and the cell-density limitation, probably due to self-shading of the cells, will have to be overcome on the way to synthetic applications.

Verified
Journal Article
Open access
PDF file
DFDaniele Florio
Daniele Florio
Anna Maria MalfitanoAnna Maria Malfitano
Anna Maria Malfitano
SSSarah Di Somma
Sarah Di Somma
CMCarolin Mügge
Carolin Mügge
Wolfgang WeigandWolfgang Weigand
Wolfgang Weigand
daniela marascodaniela marasco
daniela marasco
Platinum(II) complexes with different cinnamic acid derivatives as ligands were investigated for their ability to inhibit the aggregation process of amyloid systems derived from Aβ, Yeast Prion Protein Sup35p and the C-terminal domain of nucleophosmin 1. Thioflavin T binding assays and circular dichroism data indicate that these compounds strongly inhibit the aggregation of investigated peptides exhibiting IC50 values in the micromolar range. MS analysis confirms the formation of adducts between peptides and Pt(II) complexes that are also able to reduce amyloid cytotoxicity in human SH-SY5Y neuroblastoma cells. Overall data suggests that bidentate ligands based on β-hydroxy dithiocinnamic esters can be used to develop platinum or platinoid compounds with anti-amyloid aggregation properties.